相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Distribution of Residual Disease and Recurrence Patterns in Pathological Responders After Neoadjuvant Chemotherapy for Esophageal Squamous Cell Carcinoma
Satoru Matsuda et al.
ANNALS OF SURGERY (2022)
Exosome-based liquid biopsies in cancer: opportunities and challenges
W. Yu et al.
ANNALS OF ONCOLOGY (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer
Ronan J. Kelly et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
A phase II study of chemoselection with docetaxel, cisplatin, and 5-fluorouracil as a strategy for organ preservation in patients with resectable esophageal cancer (CROC trial).
Chikatoshi Katada et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
Risk Prediction Model of 90-Day Mortality After Esophagectomy for Cancer
Xavier Benoit D'Journo et al.
JAMA SURGERY (2021)
The Pattern of Residual Tumor After Neoadjuvant Chemotherapy for Locally Advanced Esophageal Cancer and Its Clinical Significance
Tadayoshi Hashimoto et al.
ANNALS OF SURGERY (2020)
Can Minimally Invasive Esophagectomy Replace Open Esophagectomy for Esophageal Cancer? Latest Analysis of 24,233 Esophagectomies From the Japanese National Clinical Database
Naoya Yoshida et al.
ANNALS OF SURGERY (2020)
Long-term health-related quality of life following robot-assisted radical transmediastinal esophagectomy
Kotaro Sugawara et al.
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES (2020)
Recent progress in multidisciplinary treatment for patients with esophageal cancer
Masayuki Watanabe et al.
SURGERY TODAY (2020)
Circulating Tumor DNA Analysis for Detection of Minimal Residual Disease After Chemoradiotherapy for Localized Esophageal Cancer
Tej D. Azad et al.
GASTROENTEROLOGY (2020)
Liquid Biopsy-Based Biomarkers of Treatment Response and Resistance
Elaine Kilgour et al.
CANCER CELL (2020)
Feasibility study of nivolumab as neoadjuvant chemotherapy for locally esophageal carcinoma: FRONTiER (JCOG1804E)
Shun Yamamoto et al.
FUTURE ONCOLOGY (2020)
Pembrolizumab plus chemotherapy versus chemotherapy as first-line therapy in patients with advanced esophageal cancer: The phase 3 KEYNOTE-590 study
K. Kato et al.
ANNALS OF ONCOLOGY (2020)
Multidisciplinary treatment of esophageal cancer: The role of active surveillance after neoadjuvant chemoradiation
Tania Triantafyllou et al.
ANNALS OF GASTROENTEROLOGICAL SURGERY (2020)
Personalized Detection of Circulating Tumor DNA Antedates Breast Cancer Metastatic Recurrence
Raoul Charles Coombes et al.
CLINICAL CANCER RESEARCH (2019)
Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial
Salah-Eddin Al-Batran et al.
LANCET (2019)
Analysis of Plasma Cell-Free DNA by Ultradeep Sequencing in Patients With Stages I to III Colorectal Cancer
Thomas Reinert et al.
JAMA ONCOLOGY (2019)
Esophageal cancer practice guidelines 2017 edited by the Japan esophageal society: part 2
Yuko Kitagawa et al.
ESOPHAGUS (2019)
Esophageal cancer practice guidelines 2017 edited by the Japan Esophageal Society: part 1
Yuko Kitagawa et al.
ESOPHAGUS (2019)
Robot-assisted Minimally Invasive Thoracolaparoscopic Esophagectomy Versus Open Transthoracic Esophagectomy for Resectable Esophageal Cancer A Randomized Controlled Trial
Pieter C. van der Sluis et al.
ANNALS OF SURGERY (2019)
Hybrid Minimally Invasive Esophagectomy for Esophageal Cancer
C. Mariette et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Neoadjuvant chemoradiotherapy plus surgery versus active surveillance for oesophageal cancer: a stepped-wedge cluster randomised trial
Bo Jan Noordman et al.
BMC CANCER (2018)
Detection of residual disease after neoadjuvant chemoradiotherapy for oesophageal cancer (preSANO): a prospective multicentre, diagnostic cohort study
Bo Jan Noordman et al.
LANCET ONCOLOGY (2018)
Detection and localization of surgically resectable cancers with a multi-analyte blood test
Joshua D. Cohen et al.
SCIENCE (2018)
Adjuvant Chemotherapy vs Postoperative Observation Following Preoperative Chemoradiotherapy and Resection in Gastroesophageal Cancer A Propensity Score-Matched Analysis
Ali A. Mokdad et al.
JAMA ONCOLOGY (2018)
A single-arm confirmatory study of definitive chemoradiotherapy (dCRT) including salvage treatment in patients (pts) with clinical (c) stage II/III esophageal carcinoma (EC) (JCOG0909).
Yoshinori Ito et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Application of Cell-free DNA Analysis to Cancer Treatment
Ryan B. Corcoran et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Three-field lymph node dissection in esophageal cancer surgery
Satoru Matsuda et al.
JOURNAL OF THORACIC DISEASE (2017)
Minimally Invasive Versus Open Esophageal Resection Three-year Follow-up of the Previously Reported Randomized Controlled Trial: the TIME Trial
Jennifer Straatman et al.
ANNALS OF SURGERY (2017)
The Prevalence of Overall and Initial Lymph Node Metastases in Clinical T1N0 Thoracic Esophageal Cancer From the Results of JCOG0502, a Prospective Multicenter Study
Yasunori Akutsu et al.
ANNALS OF SURGERY (2016)
Current Advancement in Multidisciplinary Treatment for Resectable cStage II/III Esophageal Squamous Cell Carcinoma in Japan
Satoru Matsuda et al.
ANNALS OF THORACIC AND CARDIOVASCULAR SURGERY (2016)
A randomized Phase III trial of thoracoscopic versus open esophagectomy for thoracic esophageal cancer: Japan Clinical Oncology Group Study JCOG1409
Kozo Kataoka et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2016)
Three-arm Phase III Trial Comparing Cisplatin Plus 5-FU (CF) Versus Docetaxel, Cisplatin Plus 5-FU (DCF) Versus Radiotherapy with CF (CF-RT) as Preoperative Therapy for Locally Advanced Esophageal Cancer (JCOG1109, NExT Study)
Kenichi Nakamura et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2013)
A Randomized Trial Comparing Postoperative Adjuvant Chemotherapy with Cisplatin and 5-Fluorouracil Versus Preoperative Chemotherapy for Localized Advanced Squamous Cell Carcinoma of the Thoracic Esophagus (JCOG9907)
Nobutoshi Ando et al.
ANNALS OF SURGICAL ONCOLOGY (2012)
Minimally invasive versus open oesophagectomy for patients with oesophageal cancer: a multicentre, open-label, randomised controlled trial
Surya S. A. Y. Biere et al.
LANCET (2012)
Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer
P. van Hagen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
PHASE II STUDY OF CHEMORADIOTHERAPY WITH 5-FLUOROURACIL AND CISPLATIN FOR STAGE II-III ESOPHAGEAL SQUAMOUS CELL CARCINOMA: JCOG TRIAL (JCOG 9906)
Ken Kato et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2011)
Perioperative Chemotherapy Compared With Surgery Alone for Resectable Gastroesophageal Adenocarcinoma: An FNCLCC and FFCD Multicenter Phase III Trial
Marc Ychou et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Validation Study of Radio-Guided Sentinel Lymph Node Navigation in Esophageal Cancer
Hiroya Takeuchi et al.
ANNALS OF SURGERY (2009)
Long-Term Results of a Randomized Trial of Surgery With or Without Preoperative Chemotherapy in Esophageal Cancer
William H. Allum et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer
David Cunningham et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Mediastinoscope-assisted transhiatal esophagectomy for esophageal cancer
A Tangoku et al.
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES (2004)
Surgery plus chemotherapy compared with surgery alone for localized squamous cell carcinoma of the thoracic esophagus: A Japan Clinical Oncology Group Study - JCOG9204
N Ando et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Improvement in the results of surgical treatment of advanced squamous esophageal carcinoma during 15 consecutive years
N Ando et al.
ANNALS OF SURGERY (2000)
分享论文
